Risperdal, Zyprexa and Invega: Studies Show Breast Cancer Connection

Risperdal Breast Cancer Lawsuits: What You Need to Know

If you’ve been diagnosed with breast cancer and have a history of taking Risperdal (risperidone), you may be wondering if there’s a connection. Risperdal is an antipsychotic medication prescribed for conditions like schizophrenia, bipolar disorder, and irritability associated with autism. While it has helped many, concerns have emerged about its potential link to breast cancer, particularly due to its effect on hormone levels.

Understanding Risperdal and Its Uses

Risperdal, known generically as risperidone, is classified as an atypical antipsychotic. It’s commonly prescribed to treat mental health conditions such as schizophrenia, bipolar disorder, and irritability in children with autism. The medication works by affecting the levels of certain neurotransmitters in the brain, helping to balance mood and behavior.

While Risperdal has been effective for many patients, it’s essential to be aware of its side effects. One significant concern is its impact on hormone levels, particularly prolactin, which can have various effects on the body.

The Link Between Risperdal and Breast Cancer

Research has indicated that Risperdal can lead to elevated levels of prolactin, a hormone responsible for breast development and milk production. High prolactin levels, a condition known as hyperprolactinemia, have been associated with an increased risk of breast tissue changes and potentially breast cancer.

Several studies have explored this connection. For instance, a study published in the journal Schizophrenia Bulletin found that women with schizophrenia treated with prolactin-elevating antipsychotics had a higher incidence of breast cancer compared to those not exposed to these medications. Another study in Breast Cancer Research highlighted that hyperprolactinemia-inducing antipsychotics could promote the progression of precancerous lesions to cancerous ones.

Who Is at Risk?

Individuals who have taken Risperdal, especially over extended periods, may be at an increased risk of developing breast cancer. Factors that can elevate this risk include:

• Long-term use of Risperdal
• High dosages of the medication
• Concurrent use of other medications that raise prolactin levels
• Personal or family history of breast cancer

It’s important to discuss any concerns with your healthcare provider, especially if you notice unusual symptoms or have a history that may predispose you to higher risks.

Symptoms of Breast Cancer Linked to Risperdal

Being vigilant about changes in your body can lead to early detection and better outcomes. Symptoms to watch for include:

• Lumps or masses in the breast or underarm area
• Changes in breast size, shape, or appearance
• Unexplained pain in the breast or nipple
• Nipple discharge that is not breast milk
• Skin changes on the breast, such as dimpling or redness

If you experience any of these symptoms, seek medical attention promptly for evaluation and diagnosis.

Risperdal Breast Cancer Lawsuits Explained

Legal actions have been initiated against the manufacturers of Risperdal, alleging that they failed to adequately warn patients and healthcare providers about the risks associated with elevated prolactin levels and the potential development of breast cancer.

These lawsuits claim that the companies were aware of the risks but did not provide sufficient warnings, leading to patients unknowingly facing increased health hazards. By pursuing legal action, affected individuals aim to hold these companies accountable and seek compensation for their suffering.

Are Some Antipsychotics Safer Than Others? Breast Cancer Risk Tied to Hormonal Impact

If you’ve been prescribed an antipsychotic drug, your risk of developing breast cancer may depend heavily on which specific medication you were given. In a major study from Washington University School of Medicine, researchers divided these drugs into three risk groups based on their ability to raise prolactin levels-a hormone now known to fuel breast cancer development.

The categories are as follows:

• High-risk (Category 1): Risperdal (risperidone), Invega (paliperidone), haloperidol
• Mid-level risk (Category 2): Zyprexa (olanzapine), iloperidone, lurasidone
• Lower-risk (Category 3): Aripiprazole, clozapine, quetiapine, ziprasidone, and others

Women on Category 1 drugs had a 62% higher chance of developing breast cancer compared to women using lithium or anticonvulsants. Category 2 users faced a 54% higher risk. But women on Category 3 drugs experienced no statistically significant increase in risk.

This data provides a clear message for patients and providers alike: long-term use of prolactin-raising antipsychotics may expose women to preventable cancer risks. These findings also strengthen legal claims against manufacturers who failed to disclose these dangers to patients or healthcare professionals.

Study link: Washington University School of Medicine.

Types of Compensation Available

Victims who have developed breast cancer after taking Risperdal may be entitled to various forms of compensation, including:

• Medical expenses, both past and future
• Lost wages and diminished earning capacity
• Pain and suffering
• Emotional distress
• Loss of enjoyment of life
• Punitive damages, in cases of gross negligence

Each case is unique, and the compensation awarded will depend on the specifics of the individual’s situation.

Prior Risperdal Lawsuits and Settlements

Over the years, numerous lawsuits have been filed against Johnson & Johnson, the manufacturer of Risperdal, concerning various side effects of the drug. Notably, in 2013, the company agreed to a $2.2 billion settlement to resolve criminal and civil investigations related to the marketing of Risperdal and other drugs (Justice Department).

In 2021, Johnson & Johnson settled approximately 9,000 lawsuits for $800 million, addressing claims that Risperdal caused male breast growth (gynecomastia) (Reuters). While these settlements primarily focused on gynecomastia, they highlight the company’s history of legal challenges related to Risperdal’s side effects.

Steps to Take if You Suspect Risperdal Caused Your Breast Cancer

If you believe your breast cancer diagnosis may be linked to Risperdal use, consider the following steps:

• Consult with your healthcare provider to discuss your medical history and concerns.
• Gather medical records, including prescriptions and treatment details.
• Document any symptoms and their progression.
• Seek legal advice to understand your rights and potential for compensation.

Taking these steps can help you build a strong case and ensure that you receive the support and justice you deserve.

How an Experienced Lawyers Can Help

Navigating a lawsuit can be complex and overwhelming, especially when dealing with health challenges. Our experienced lawyers can:

• Evaluate the merits of your case
• Gather and analyze medical and pharmaceutical evidence
• Handle all legal filings and communications
• Negotiate settlements or represent you in court
• Provide guidance and support throughout the legal process

Our attorneys work on a contingency fee basis, meaning they only get paid if you win your case, allowing you to pursue justice without upfront legal fees.

Frequently Asked Questions

• Can Risperdal cause breast cancer? While direct causation is complex to establish, studies have shown that Risperdal can elevate prolactin levels, which may significantly increase the risk of breast tissue changes and potentially breast cancer.
• How long do I have to file a lawsuit? The statute of limitations varies by state, typically ranging from one to several years from the date of diagnosis or discovery of the link between the medication and the condition.
• What compensation can I expect? Compensation varies based on individual circumstances, including medical expenses, lost income, and pain and suffering. Our attorneys can provide a more accurate estimate based on your case.
• Will I have to go to court? Many cases are settled out of court. However, if a fair settlement isn’t reached, your attorney may recommend proceeding to trial to seek appropriate compensation.

Contact Our Risperdal Breast Cancer Lawyers Today

If you’ve been diagnosed with breast cancer and have a history of Risperdal use, it’s essential to explore your legal options. Our experienced attorneys at Alonso Krangle, LLP are here to help you navigate the complexities of your case with compassion and dedication.

Don’t face this challenge alone. Contact us today at 800-403-6191 for a free consultation to discuss your situation and determine the best course of action for seeking the justice and compensation you deserve.

Related pages:

[child_pages list=”true” cols=”2″]